Cartesian Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Cartesian Therapeutics, Inc. (RNAC) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $3.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $4.79M.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$850.00K.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $1.06M, a 8.94% decline year-over-year.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$432.00K, a 172.97% decline year-over-year.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$3.59M.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$6.74M.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$2.76M, a 224.82% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $2.21M, a 108.48% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.94M 10-Q · filed 2026-08-06 | $5.00M derived: sum of 3 quarters · filed 2026-08-06 | $4.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$850.00K 10-Q · filed 2026-04-30 | $209.00K derived: sum of 2 quarters · filed 2026-04-30 | -$223.00K derived: sum of 3 quarters · filed 2026-04-30 | -$2.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $627.00K derived: sum of 2 quarters · filed 2026-03-09 | -$1.41M derived: sum of 3 quarters · filed 2026-08-06 | -$3.59M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.47M derived: sum of 2 quarters · filed 2026-08-06 | -$4.65M 10-Q · filed 2025-11-06 | -$3.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.21M 10-Q · filed 2026-08-06 | -$3.05M derived: sum of 3 quarters · filed 2026-08-06 | -$2.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.18M 10-Q · filed 2026-04-30 | -$1.01M derived: sum of 2 quarters · filed 2026-04-30 | -$423.00K derived: sum of 3 quarters · filed 2026-04-30 | -$2.49M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.75M derived: sum of 2 quarters · filed 2026-03-09 | -$315.00K derived: sum of 3 quarters · filed 2026-03-09 | -$6.74M 10-K · filed 2026-03-09 |
| 2024-09-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.48M derived: sum of 2 quarters · filed 2025-11-06 | -$7.90M 10-Q · filed 2025-11-06 | -$9.03M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$8.50M 10-Q · filed 2025-08-07 | -$9.62M derived: sum of 3 quarters · filed 2025-08-07 | -$7.58M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$6.43M 10-Q · filed 2025-05-08 | -$7.55M derived: sum of 2 quarters · filed 2025-05-08 | -$5.51M derived: sum of 3 quarters · filed 2025-05-08 | -$3.83M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $912.00K derived: sum of 2 quarters · filed 2025-03-13 | $2.60M derived: sum of 3 quarters · filed 2025-03-13 | -$2.76M 10-K · filed 2025-03-13 |
| 2023-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.72M derived: sum of 2 quarters · filed 2024-11-07 | -$1.64M 10-Q · filed 2024-11-07 | -$61.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.67M 10-Q · filed 2024-08-08 | -$2.10M derived: sum of 3 quarters · filed 2024-08-08 | -$2.43M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$5.36M 10-Q · filed 2024-05-08 | -$3.78M derived: sum of 2 quarters · filed 2024-05-08 | -$4.11M derived: sum of 3 quarters · filed 2024-05-08 | -$925.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.25M derived: sum of 2 quarters · filed 2024-03-07 | $4.43M derived: sum of 3 quarters · filed 2024-03-07 | $2.21M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.86M derived: sum of 2 quarters · filed 2023-11-13 | $635.00K 10-Q · filed 2023-11-13 | -$44.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $965.00K 10-Q · filed 2023-08-17 | $286.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.96M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$2.22M 10-Q · filed 2023-05-04 | -$2.90M derived: sum of 2 quarters · filed 2024-03-07 | -$1.23M derived: sum of 3 quarters · filed 2024-03-07 | $575.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$679.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $991.00K derived: sum of 2 quarters · filed 2024-03-07 | $2.80M derived: sum of 3 quarters · filed 2024-03-07 | $1.06M 10-K · filed 2024-03-07 |
| 2021-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.48M derived: sum of 2 quarters · filed 2022-11-03 | $1.74M 10-Q · filed 2022-11-03 | -$1.41M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $70.00K 10-Q · filed 2022-08-08 | -$3.08M derived: sum of 3 quarters · filed 2023-03-02 | -$2.33M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$1.74M 10-Q · filed 2022-05-05 | -$4.89M derived: sum of 2 quarters · filed 2023-03-02 | -$4.13M derived: sum of 3 quarters · filed 2023-03-02 | -$3.67M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | -$3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$2.40M derived: sum of 2 quarters · filed 2023-03-02 | -$1.93M derived: sum of 3 quarters · filed 2023-03-02 | -$2.76M 10-K · filed 2023-03-02 |
| 2020-09-30 | $751.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.22M derived: sum of 2 quarters · filed 2021-11-09 | $389.00K 10-Q · filed 2021-11-09 | $5.04M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$362.00K 10-Q · filed 2021-08-12 | $4.29M derived: sum of 3 quarters · filed 2022-03-10 | $3.47M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | -$829.00K 10-Q · filed 2021-05-13 | $3.82M derived: sum of 2 quarters · filed 2022-03-10 | $3.00M derived: sum of 3 quarters · filed 2022-03-10 | $392.00K derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $3.83M derived: sum of 2 quarters · filed 2022-03-10 | $1.22M derived: sum of 3 quarters · filed 2022-03-10 | -$2.40M 10-K · filed 2022-03-10 |
| 2019-09-30 | -$815.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$3.43M derived: sum of 2 quarters · filed 2020-11-05 | -$7.05M 10-Q · filed 2020-11-05 | -$6.34M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | -$2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$6.23M 10-Q · filed 2020-08-06 | -$5.53M derived: sum of 3 quarters · filed 2021-03-12 | -$4.93M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$3.62M 10-Q · filed 2020-05-07 | -$2.92M derived: sum of 2 quarters · filed 2021-03-12 | -$2.32M derived: sum of 3 quarters · filed 2021-03-12 | -$1.55M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $701.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.30M derived: sum of 2 quarters · filed 2021-03-12 | $2.06M derived: sum of 3 quarters · filed 2021-03-12 | $2.47M 10-K · filed 2021-03-12 |
| 2018-09-30 | $599.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.36M derived: sum of 2 quarters · filed 2019-11-08 | $1.77M 10-Q · filed 2019-11-08 | $3.65M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $763.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.17M 10-Q · filed 2019-08-08 | $3.05M derived: sum of 3 quarters · filed 2020-03-12 | $1.18M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $404.00K 10-Q · filed 2019-05-09 | $2.29M derived: sum of 2 quarters · filed 2020-03-12 | $418.00K derived: sum of 3 quarters · filed 2020-03-12 | $4.64M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $14.00K derived: sum of 2 quarters · filed 2020-03-12 | $4.24M derived: sum of 3 quarters · filed 2020-03-12 | $5.65M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.35M derived: sum of 2 quarters · filed 2018-11-08 | $3.77M 10-Q · filed 2018-11-08 | $5.25M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $5.64M 10-Q · filed 2018-08-08 | $7.12M derived: sum of 3 quarters · filed 2019-03-15 | $6.22M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $1.41M 10-Q · filed 2018-05-09 | $2.89M derived: sum of 2 quarters · filed 2019-03-15 | $2.00M derived: sum of 3 quarters · filed 2019-03-15 | $2.71M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $589.00K derived: sum of 2 quarters · filed 2019-03-15 | $1.30M derived: sum of 3 quarters · filed 2019-03-15 | $716.00K 10-K · filed 2019-03-15 |
| 2016-09-30 | -$890.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$182.00K derived: sum of 2 quarters · filed 2017-11-07 | -$763.00K 10-Q · filed 2017-11-07 | -$374.00K derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $708.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $127.00K 10-Q · filed 2017-08-11 | $516.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.06M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | -$581.00K 10-Q · filed 2017-05-11 | -$192.00K derived: sum of 2 quarters · filed 2018-03-15 | $352.00K derived: sum of 3 quarters · filed 2018-03-15 | |
| 2015-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $933.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.26M 10-K · filed 2018-03-15 | |
| 2015-09-30 | $544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $870.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $326.00K 10-Q · filed 2016-08-09 | |||
| 2014-12-31 | $415.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |